SEC Form 4 · accession 0001209191-16-108163

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Scientific Officer

Period of report

Mar 10, 2016

Accepted (ET)

Mar 14, 2016 · 5:15 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001077183

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 10, 2016	M	50,000	$1.48	A	55,953	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1	$1.48	Mar 10, 2016	X	50,000	D	May 16, 2012	May 16, 2016	Common Stock	50,000	0	D
Stock Option (Right to Buy)^F2	$1.69	holding	—	—	—	Apr 12, 2012	Apr 12, 2017	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$3.76	holding	—	—	—	Apr 16, 2014	Apr 16, 2018	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F4	$3.45	holding	—	—	—	Mar 5, 2015	Mar 5, 2019	Common Stock	20,000	20,000	D
Stock Option (Right to Buy)^F5	$4.78	holding	—	—	—	May 4, 2016	May 4, 2020	Common Stock	120,000	120,000	D

F1On May 16, 2011 Dr. Brodie was granted 50,000 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F2On April 12, 2012 Dr.Brodie was granted 10,000 stock options. There was immediate vesting of 2,500 shares and then 2,500 shares will vest on the next three anniversary dates of the grant date.
F3On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
F4On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
F5On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.